PIC
JWBK208-23 December 8, 2007 21:30 Char Count= 0
Infection and Immunity 351
Common Variable Immunodeficiency (CVID)
r
Usu. sporadic (late onset), some are familial (early onset)
r
B-cells can’t mature to plasma cells (and there is also T-cell dysfunction which may result in the
granulomatous form of CVID)
r
↓Serum IgG, IgA, ± IgM; ±↓CD4 count (! d/dg AIDS)
General features
r
Lack of plasma cells in tissues (esp. noticeable in the GIT MALT)
r
Lymphoid follicular hyperplasia
r
± Granulomas in many organs (d/dg Sarcoidosis, etc.)
r
↑ risk of NHL (incl. MALToma)
r
↑ risk of all types of infection e.g. Giardia, Cryptosporidia, viruses, Haemophilus influenzae, fungi
r
↑ risk of autoimmune disorders (e.g. AIH)
Specific organs
r
LN: follicular hyperplasia ± granulomas, ± NHL
r
Lung: LIP ± MALToma
r
Liver: viral hepatitis/AIH/granulomas
r
Kidney: mesangial and paramesangial immune complexes ± interstitial granulomas
r
GIT: nodular lymphoid hyperplasia, villous atrophy, Giardia, Cryptosporidia, CMV, Candida, granu-
lomas, etc., absence of plasma cells (see also pp. 142 and 148)
Antiphospholipid Antibody Syndrome (Anticardiolipin Antibody or Hughes’ Syndrome)
r
Def
n
: persistent antiphospholipid Abs + TMA/thrombocytopenia ± recurrent IUD
r
Due to a prothrombotic (in vivo) antiphospholipid Ab (e.g. anticardiolipin) that occur in SLE and other
conditions. These inhibit coagulation tests in vitro (so also called ‘lupus inhibitor’/‘lupus anticoagulant’)
and requires immunosuppression +/ anticoagulant cover (or may be self limited)
r
Non-thrombogenic antiphospholipid Abs (which .
.
. do not cause the syndrome) occur with many infec-
tions (incl. HCV, HIV, bacterial, etc.), drugs (incl. antibiotics and cocaine) and some normals
r
Pathology is that of a TMA (see pp. 61–62, p. 71 and p. 207)
r
d/dg the vasculitis of CTD/lupus (see p. 71)
r
d/dg clinically it may be misdiagnosed as MS
The Concept of Granuloma
r
Definition of granuloma: ‘chronic inflammation in the form of a mass’ was the original definition.
Some modern student texts prefer ‘a collection of epithelioid histiocytes’.
r
However, the following terminologies only make sense in the light of the original definition (although
some are now known to be neoplastic): pyogenic granuloma, foreign body granuloma, xanthogranu-
loma (juvenile), eosinophil granuloma (HX), nodular paragranuloma, plasma cell granuloma, D¨urck’s
granuloma, etc.
r
Furthermore, diffuse epithelioid granulomatous inflammation (= swathes of epithelioid histiocytes), not
being a tight collection, may be underdiagnosed by those adhering to the simplistic student-definition
of ‘granuloma’
Bibliography
Allason-Jones, E. (1987) The Gay Bowel Syndrome. British Journal of Hospital Medicine, 38 (5), 397.
Chandler, F. and Watts, C. (1987) Pathologic Diagnosis of Fungal Infections,1
st
edn, American Society of Clinical Pathologists Press, Chicago.
Chapel, H. and Haeney, M. (1988) Essentials of Clinical Immunology,2
nd
edn, Blackwell Scientific Publications, Oxford.
Connor, D.H., Chandler, F.W., Schwartz, D.A. et al. (eds) (1997) Pathology of Infectious Diseases,1
st
edn, Appleton & Lange, Stamford, Connecticut.
Cotran, R.S., Kumar, V. and Collins, T. (eds) (1999) Robbins Pathologic Basis of Disease,6
th
edn, W.B. Saunders Co., Philadelphia.
Duerden, B.I., Reid, T.M.S., Jewsbury, J.M. et al. (1987) A New Short Textbook of Medical Microbiology,1
st
edn, Edward Arnold (Hodder &
Stoughton), London.
Eapen, M., Mathew, C.F. and Aravindan, K.P. (2005) Evidence based criteria for the histopathological diagnosis of toxoplasmic lymphadenopathy.
Journal of Clinical Pathology, 58 (11), 1143–1146.
Goedert, J.J., Cot´e, T.R., Virgo, P. et al. (1998) Spectrum of AIDS-associated malignant disorders. The Lancet, 351 (9119), 1833–1839.
Gotuzzo, E., Terashima, A., Alvarez, H. et al. (1999) Strongyloides stercoralis hyperinfection associated with human T cell lymphotrophic virus type
1 infection in Peru. American Journal of Tropical Medicine and Hygeine, 60 (1), 146–149.
Hale, M.J. (2000) Mycobacterial infection: a histopathological chameleon. Current Diagnostic Pathology, 6 (2), 93–102.
Harada, M., Fujisawa, Y., Sakisaka, S. et al. (2000) High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on
thrombocytopaenia and thrombotic complications. Journal of Gastroenterology, 35 (4), 272–277.